Seeking Alpha

SGEN
  Seattle Genetics, Inc. - NASDAQ

9/17/2014, 5:35 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
SGEN vs. ETF Alternatives
Company Description
Seattle Genetics Inc is a biotechnology company. It develops and commercializes monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease.
Sector: Healthcare
Industry: Biotechnology
Country: United States